This number was reduced to 15 and 25 genes for SK1 and SK2 KD, respectively, in prostate cells and 25 and 8 genes for SK1 and SK2 KD, respectively, in breast cancer cells (Figure 2–5, 7). This evidence concerns the gene SPHK2 and breast cancer.